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GENERAL THORACIC SURGERY 
TREATMENT STRATEGIES 
FOR BRONCHOPLEURAL 
FISTULA 
Successful management of chronic postoperative bronchopleural fistula remains a 
challenge for thoracic surgeons. Forty-two patients (33 referred from other institu- 
tions) were treated for major postoperative bronchopleural fistula since 1978. 
Factors associated with bronchopleural fistula included right pneumonectomy (n = 
23), left pneumonectomy (n = 8), long bronehial stump (n = 16), pneumonia (n = 
13), radiation therapy (n = 12), stapled bronchial closure (n = 8), prolonged 
mechanical ventilation (n = 7), recurrent carcinoma (n = 6), and tuberculosis (n = 
2). Patients had undergone an average of 3.3 surgical procedures to correct heir 
bronchopleurai fistulas during a mean interval of 24 months before our treatment. 
Bronchopleural fistulas were located in the right main bronchial stump (n = 23), left 
main bronchial stump (n = 8), right lobar bronchial stumps (n = 10), and 
tracheobronchial anastomosis (n = 1). Thirty-five patients were treated by snture 
closure of the bronchial stump, buttressed with vascularized pedicle flaps of 
omentnm (n = 19), muscle (n = 13), or pleura (n = 2). In seven cases, direct snture 
closnre was not possible, and omental (n = 6) or muscle (n = 1) flaps were sutured 
over the bronchopleural fistula. Suture closure without pedicle coverage was 
performed successfully in one case. Initial repair of the fistula was successful in 23 
of 25 patients treated with omentum, in nine of 14 patients treated with muscle and 
in neither of two patients treated with pleural flaps. In nine patients with persistent 
or recurrent bronchopleural fistula after our initial repair, four underwent a second 
procedure (three successful) and five were managed with drainage only. The fistula 
was successfully closed in 11 of 12 patients who had received high-dose radiation 
therapy (nine with omentum). Overall, successful closure of bronchopleural fistula 
was achieved in 36 of 42 patients (86%). Four in-hospital deaths resulted from 
pneumonia nd sepsis, two in patients with recurrent bronchopleural fistula after 
pleural flap closure. In 16 patients the empyema cavity was obliterated uring 
defnitive repair of the fistula. The cavity resolved with drainage in four others, nine 
had draining cavities at follow-up, and one was lost to follow-up. Ten patients 
required a total of 17 Clagett procedures and one had a delayed myoplasty. Direct 
surgical repair of chronic bronchopleural fistula may be achieved in most patients 
after adequate pleural drainage by suture closure and aggressive transposition of 
vascularized pedicle flaps. Omentum is particularly etfective in buttressing the 
closure of bronchopleural fistulas. (J THORAC CARDIOVASC SURG 1995;109:989-96) 
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S uccessful management of postresection bron- chopleural fistula (BPF) has historically been a 
major challenge for thoracic surgeons 1'2 and re- 
mains so today. 3-6 In the early antimicrobial era, 
pneumonectomy for tuberculosis carried a risk of 
BPF as high as 28%. 7 The best way to manage 
postoperative BPF is to prevent he problem at the 
time of pulmonary resection. Every attempt should 
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be made to avoid disruption of the bronchial blood 
supply, rough handling of the bronchial mucosa, 
excessive suture tension, and steroid administration. 
It has been our practice to use absorbable sutures 
and to cover all bronchial stumps with pedicled 
pleura, pericardial fat pads, or even pediculed inter- 
costal muscle in high-risk situations. A recent mul- 
tivariate analysis by Asamura and associates 8 of risk 
factors for BPF in 1360 pulmonary resections for 
lung cancer identified right-sided resection, pneumo- 
nectomy (especially right pneumonectomy), mediasti- 
nal lymph node dissection, high-dose preoperative 
radiation therapy, and residual/recurrent carcinoma t 
the bronchial stump as technical factors predisposing 
to BPF. Nonoperative predisposing conditions in- 
cluded diabetes mellitus, hypoalbuminemia, hepatic 
cirrhosis, and steroid administration. 8 Despite wide- 
spread understanding of these principles, the modern 
reported incidence of major BPF after pulmonary 
resection varies from 2.1% to almost 10%. 3, s-ll 
The initial management of patients with BPF 
must include thorough drainage of the infected 
pleural space, antibiotics to treat the infection, 
protection, and adequate clearänce of secretions 
from the remaining lung. Drainage may be either 
closed or open so long as it is dependent and 
complete. Once the infection has been brought 
under control, the challenge remains to close the 
fistula and manage the residual space. A vast array 
of techniques have been used to accomplish these 
goals, ranging from thoracoplasty, 12 myoplasty, 13
omentoplasty, 14 and completion pneumonectomy 15 
to aggressive combinations of these procedures. 4 
Biologic glues have been applied bronchoscopically 
to achieve endobronchial c osure of BPF in several 
case reportsJ 6' 17 Despite these various measures, 
postresection BPF carries a mortality ranging from 
16.4% 9 to 71.2%. 3, s Successful treatment of post- 
resection BPF requires adherence to the principles 
of management, aggressive control of infection, and 
an individualized approach to each patient. We 
sought to review our own experience with this 
dreaded complication to clarify treatment strategies 
for BPF. 
Methods 
We reviewed the records of all patients who had been 
treated for postoperative BPF at the Massachusetts Gen- 
eral Hospital from 1978 through 1993. Follow-up was by 
office records, a written questionnaire, and telephone 
interviews. Follow-up was complete for 40 of 42 patients 
for a mean of 37.8 months (range 1 to 153 months). 
The details of the original operation and subsequent 
treatment were carefully reviewed for each patient. Par- 
ticular attention was paid to the technique of the initial 
surgical resection, performance of lymphadenectomy, 
method of bronchial closure, and prior radiation therapy. 
Most patients had a chest x-ray film and chest computed 
tomographic scan to assess the status of the fistula, 
residual space, and remaining lung. A bronchoscopic 
examination was routinely performed to assess the loca- 
tion and size of the BPF. Thoracoscopy via the drainage 
tract was done to assess the size of the cavity, degree of 
contamination, and adequacy of drainage. Ventilation 
scintillation scanning with inhaled radionuclides was per- 
formed in two patients to confirm the presence of pinpoint 
BPFs undetected by other methods. 
Surgical technique. The technique of muscle flap mo- 
bilization and transposition has been well described else- 
where.4,13, 18 We19 have previously described the tech- 
nique of omental mobilization/pedicle advancement. The 
omentum derives its blood supply from the right and left 
gastroepiploic vessels, which form a vascular arcade within 
the omentum. Das 2° determined that detaching the omen- 
turn from the transverse colon provides ufficient length to 
reach nipple level in 75% of patients. Division of the left 
gastroepiploic vessels and detachment of the gastroepi- 
ploic arch from the greater curvature of the stomach 
creates a large omental pedicle based on intact right 
gastroepiploic vessels, which allows the mobilized omen- 
tum to reach the base of the heck in 88% and the axilla in 
70% of patients. Most commonly, the omentum is trans- 
posed to the thoracic avity for closure of a BPF via a 
substernal route. It can be placed initially in the substernal 
tunnel and the abdomen can be closed. The omentum can 
then be passed through an opening in the mediastinal 
pleura if it is to be used in an infected area of the thoracic 
cavity. This precaution may lessen the theoretical risk of 
intraabdominal sepsis. Alternatively, the omentum ay be 
passed through an opening in the diaphragm directly into 
either the left or right thoracic avity. The opening in the 
diaphragm should be fashioned to avoid compression of 
the omental vessels and yet not allow intestinal herniation. 
Results 
Original operations. Nine patients had under- 
gone their original pulmonary resections at the 
Massachusetts General Hospital; 33 patients were 
referred to our institution for management of their 
BPF. There were 33 men and 9 women, with a mean 
age of 58.7 _+ 9.8 years (range 31 to 73 years). 
Original pulmonary resections resulting in BPF 
were performed for carcinoma (n = 32), tuberculo- 
sis (n = 4), aspergillosis (n = 2), postpneumonic 
abscess (n = 1), posttraumatic abscess (n = 2), and 
destruction of main-stem bronchus by thoracic aor- 
tic aneurysm (n = 1). 
Assoeiated faetors. Factors associated with BPF 
included right pneumonectomy (n = 23), left pneu- 
monectomy (n = 8), bronchial stump 2 cm or larger 
(n = 16), pneumonia (n = 13), radiation therapy 
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(n = 12), stapled bronchial closure (n = 8), pro- 
longed mechanical ventilation (n = 7), recurrent 
carcinoma (n = 6), and tuberculosis (n = 2). 
Patients who had received prior irradiation had 
been treated with between 4000 and 6800 cGy, from 
1 month to 10 years before closure of the BPF. 
Prior treatment. Patients referred from other 
institutions for management of BPF had undergone 
an average of 3.3 surgical procedures to treat their 
BPFs (fange 1 to 19). The mean interval was 24 
months between diagnosis of BPF and referral. 
These surgical procedures had almost universally 
included attempts at tube thoracostomy or open 
drainage and orten had included various attempts at 
suture closure of the BPF, with or without horaco- 
plasty, or myoplasty (Table I). 
Location of BPFs. BPFs were located in the right 
main bronchial stump (n = 23), right lobar bron- 
chial stumps (n = 10), left main bronchial stump 
(n = 8), and tracheobronchial anastomosis (n = 1). 
Nineteen BPFs were greater than 1 cm in diameter. 
Thirteen patients had bronchopleurocutaneous fis- 
tulas that were plainly audible through open drain- 
ing cavities on physical examination. 
Initial management of empyema space. Thor- 
ough drainage of any remaining empyema space is a 
sine qua non of successful management of postop- 
erative BPF and was achieved for all patients. 
Irrigations of the space (most frequently with sterile 
saline but occasionally with dilute povidone-iodine 
[Betadine], DaNn's, or antibiotic solution) were 
performed, usually three times daily. Whenever 
feasible, patients with large BPFs and large open 
thoracostomies were treated with débriding dressing 
changes. If necessary, patients were discharged 
home for daily irrigations and dressing changes by 
visiting nurses. Great care was taken to avoid con- 
tamination of the patient's remaining lung with 
empyema fluid or irrigation solution. Any infection 
of the contralateral lung was vigorously treated with 
intravenous antibiotics guided by cultures of sputum 
and empyema fluid. Thoracostomy drainage (either 
via tube or open window) and irrigations/dressings 
were continued until the space was rendered 
clean--as determined by thoracoscopic nspection. 
Only after these conditions were achieved was de- 
finitive surgical repair of the BPF considered. The 
interval between drainage of empyema nd repair of 
BPF varied from 2 days to several weeks, depending 
on the degree of contamination and the rate of 
cleansing of the pleural spaee. During this interval 
each patient's nutritional status was maximized. This 
Table I. Prior treatment of BPF in 33 patients 
Tube drainage 48 
Open drainage 39 
Suture closure 12 
Thoracoplasty 2 
Intercostal muscle flap 2 
Pectoralis flap 2 
Pleural flap 1 
Completion pneumonectomy 1 
Endobronchial glue 1 
sometimes necessitated placement of enteral feed- 
ing tubes or parenteral hyperalimentation catheters. 
The pleural space was cultured before surgical re- 
pair to guide selection of antibiotics. 
Surgical repair. In our 42 primary repairs of 
BPF, thoracotomy was performed on the same side 
as the previous pulmonary resection in 36 cases (30 
right, 7 left). Right thoraeotomy was performed for 
a right main-stem bronchial BPF in one patient who 
had undergone transsternal right upper lobe sleeve 
resection and in one patient who had a right lower 
lobe BPF caused by cavitary tuberculosis. A right 
thoracotomy was done to resect he open left main- 
stem bronchial stump after previous left pneumo- 
nectomy in one patient. Early in our experience, a 
transsternal/transpericardial approach to the right 
main-stem bronchus was chosen in two patients with 
bronchial stumps greater than 2 cm. In four reop- 
erations for persistent or recurrent BPFs, three right 
thoracotomies were redone twice and one patient 
had a right thoraeotomy toresect he left main-stem 
bronchial stump after failed repair of a left main- 
stem bronchial BPF after left pneumonectomy. 
Sixteen patients whose bronchial stumps were 2 
cm in length or more had reresection of the bron- 
chus before suture closure. Primary suture closure 
(with 3-0 or 4-0 Vicryl suture; Ethicon, Inc., Somer- 
rille, N.J.) of the bronchial stump was possible in 35 
cases. The closure was buttressed with vascularized 
pedicle flaps of omentum (n = 19), muscle (n --- 13), 
or pleura (n = 2). In seven cases, direct suture 
closure was not possible, and omental (n = 6) or 
muscle (n = 1) flaps were carefully sutured over the 
BPF, achieving an airtight seal. Suture closure with- 
out pedicle coverage was performed successfully in
one case. In the four reexplorations for persistent/ 
recurrent BPF, secondary repairs were buttressed 
with omentum (n = 2) and muscle (n = 2). 
A total of 21 patients had muscle flaps to buttress 
primary closure of BPF (n = 14), to fill a residual 
pleural space after omental closure of BPF (n = 6), 
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Table II. Muscle pedicles used in 21 patients 
Intercostal muscle 8 
Serratus anterior 8 
Latissimus dorsi 7 
Bilateral latissimus dorsi 1 
Pectoralis major 5 
Sternohyoid 2 
Thoracoplasty ->3 ribs 5 
or in a secondary repair of a failed omental closure 
(n = 1). The various muscle flaps used in our 
patients are presented in Table II. 
Mortality. Four postoperative deaths occurred 
(9.5%). All deaths were related to pulmonary sepsis. 
Two patients had early recurrent BPF after suture 
closure and pleural flap coverage. The other two 
patients died of pneumonia nd multisystem organ 
failure with closed BPFs. 
Management of plenral space. Management of 
the residual pleural space was variable. In 16 pa- 
tients, the empyema cavity was successfully obliter- 
ated at the time of repair of the BPF. In five of the 
25 patients treated with omentum, myoplasty with or 
without limited thoracoplasty was performed con- 
comitantly in an effort to fill the pleural cavity. Six 
cavities were successfully obliterated by omentum 
only and three by a combination of omentum, 
muscle flaps, thoracoplasty, or a combination 
thereof. Seven cavities were obliterated with muscle 
flaps alone. Remaining cavities resolved with drain- 
age in five cases. Nine patients had draining cavities 
at most recent follow-up and one patient with a 
draining cavity was lost to follow-up. One patient 
underwent delayed myoplasty after successful 
omental closure of BPF. 
The Clagett procedure 2~ was performed in 10 
patients to manage a residual pleural cavity after 
successful closure of BPF. Antibiotics were selected 
on the basis of pleural cultures. In six patients a 
single Clagett procedure was curative (60% initial 
success rate). Four patients underwent multiple 
procedures (range two to five procedures per pa- 
tient). Success was achieved in two patients, one 
patient died, and the fourth has a stable draining 
cavity. The overall success rate for the Clagett 
procedure was 80% (8/10). 
Fate of the BPF. Initial closure was successful in 
33 of 42 patients (78.6%). Omental buttressing was 
successful in 23 of 25 patients (92%), muscle in nine 
of 14 patients (64%), and no success was achieved in 
those BPFs buttressed with pleura (0/2). Successful 
closure was achieved in one patient treated by 
simple suture closure without buttress after left 
pneumonectomy. 
Nine patients had either persistent or recurrent 
BPF after our initial repair. Four of these patients 
underwent a second procedure (three successful) 
and five were managed with drainage only. One 
patient who had completion right pneumonectomy 
and muscle flap buttress for radiation ecrosis of the 
right upper lobe bronchus had a recurrent BPF and 
was successfully treated with a second suture closure 
and omental buttress, followed by a delayed Clagett 
procedure. The second patient initially had suture 
closure of the right upper lobe bronchus with muscle 
flap buttress and thoracoplasty; recurrent BPF was 
successfully treated with a second suture closure and 
omental buttress. The third patient initially had an 
omental onlay closure of a left main-stem BPF; 
recurrent BPF was successfully managed by reexci- 
sion of the left main-stern bronchus with intercostal 
muscle buttress via a right thoracotomy. The fourth 
patient had an unsuccessful intercostal muscle onlay 
closure of a right main-stem BPF and had a second 
muscle onlay and subsequent Clagett procedure; a
recurrence of BPF 9 months later resulted in sepsis 
and death. 
BPF was successfully closed in 11 of 12 patients 
who had received prior irradiation (4000 to 6800 
cGy), nine with omentum and two with muscle. 
Initial repair of BPF was successful in 28 of 35 
(80%) patients treated by direct suture closure and 
vascularized pedicle buttress. In live of seven (71%) 
patients in whom direct bronchial closure was not 
possible, the BPF was successfully closed by our 
initial repair. Overall, successful c osure of BPF was 
achieved after primary and secondary procedures in
36 of 42 patients (86%). 
Discnssion 
BPF is best managed by avoiding the complica- 
tion altogether. Postoperative BPF has become less 
prevalent with advances in surgical technique based 
on several principles, including gentle handling of 
tissues, precise placement of sutures, bronchial clo- 
sure without tension, avoidance of long bronchial 
stump and excessive dissection, assurance of dis- 
ease-free bronchial margin, preoperative control of 
infection, and aggressive nutritional support of the 
patient. 22 We also believe that use of absorbable 
simple sutures (4-0 Vicryl sutures) and routine 
coverage of all bronchial stumps with a vascularized 
flap contribute to a reduced rate of BPF. Coverage 
has been accomplished most commonly with the 
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pedicled pericardial fat pad whenever feasible, be- 
cause it has been shown both experimentally and 
clinically to reduce the prevalence of BPF .  22' 23 
When this is not feasible, apleural flap or intercostal 
muscle pedicle is used. The pleural flap has little 
bulk and vascularity and may not be optimal for 
coverage of pneumonectomy stumps. 
During the 15-year period of this study, only nine 
BPFs occurred in 1661 pulmonary resections at the 
Massachusetts General Hospital (a rate of 0.5%). 
Eight of these patients had pneumonectomies and 
one had a right upper lobectomy. Four of these 
bronchial stumps had been covered with pleural 
flaps in our early experience, three with pericardial 
fat, one with an azygos vein pedicle, and orte with an 
intercostal muscle flap. 
Risk factors associated with BPF in the present 
series are consistent with the findings of Asamura 
and associates, s Of special eoncern are patients who 
undergo right pneumonectomy after preoperative 
irradiation in excess of 5000 cGy. If diabetes, mal- 
nutrition, advanced age, steroid administration, or a 
combination of these are concomitant factors, the 
risk of BPF is increased. Under these circumstances 
use of an intercostal muscle flap or even an omental 
pedicle reinforcement of the bronchial closure 
should be considered prophylactieally at the time of 
pneumonectomy. This measure has been effective in 
reconstruction of the previously irradiated traehea 
and bronchus. 24 
When a BPF occurs it is most important to ensure 
proper drainage of the pleural space and control of 
infection in the remaining lung. Definitive repair 
should be delayed until the patient is in optimal 
condition and the eavity is clean. This ensures the 
greatest chance for success. We prefer a direct 
transthoracic approach on the same side as the 
fistula in most cases, regardless of the length of the 
bronchial stump. We have found this approach 
suitable even for patients previously treated with 
high-dose irradiation. For long bronchial stumps the 
median sternotomy transpericardial pproach is an 
alternative approach. However, it provides less ex- 
posure, may present difficulties in removing the 
bronchial stump, and always necessitates a second 
procedure to close the pleural cavity. The fistula can 
always be identified by ventilating above the level of 
the affected bronchus. A dense thick peel is encoun- 
tered, making dissection tedious and difficult, but 
with care and patience the fistula can be unroofed 
until normal bronchus is encountered. Dissection 
should be kept on the bronchus at all times to avoid 
nearby vascular structures including the divided end 
of the pulmonary artery. Long bronchial stumps 
should be reresected to healthy tissue and closed 
with absorbable sutures. This procedure achieves 
two benefits: pooling of infected secretions i  pre- 
vented and fresh bronchial tissue is used in the 
closure, promoting healing. Retention of residual 
distal stumps, such as after a transsternal pproach 
with bronchial division or stapling only, may lead to 
recurrent empyema. 25When the stump is too short 
or rigid or the fistula too large to allow direct 
closure, the chosen vascularized flap (muscle or 
omentum) is carefully sewn to the edges of the 
fistula as if for an anastomosis to achieve an airtight 
seal. We have preferred interrupted fine absorbable 
sutures for this. Each patient must be treated indi- 
vidually and the the best approach chosen on the 
basis of the unique set of circumstances presented. 
We prefer to buttress all fistula repairs with 
vascularized tissue. We believe that the omentum is 
superior to muscle or pleural flaps as evidenced 
by the 92% success rate for omentum versus 64% 
for muscle. Three unique properties of omentum 
make it an ideal pedicle flap for treating BPF. The 
ability of omentum to induce angiogenesis and 
neovascularity may be its most important property. 
Goldsmith and associates 26have demonstrated an 
angiogenesis factor in omental fat. Morgan and 
colleagues 27showed that totally ischemic bronchial 
tissue may be revascularized within 4 days after 
omental wrapping. Bronchial omentopexy has been 
shown to reduce the frequency of bronchial anasto- 
motic complications in canine lung autotransplanta- 
tion 2s and allotransplantation. 29 Omentum has been 
shown to revascularize other ishcemic organs includ- 
ing brain, heart, and extremities 3°' 31 and to relieve 
chronic lymphedema. 32 A second important prop- 
erty of omentum is its ability to function in the 
presence of established infection. It not only sur- 
vives, but aids in the elimination of infection. 32 This 
property is often demonstrated in the omentum's 
natural role as "policeman of the abdomen." Third, 
the bulk and amorphous hape of the omentum 
allow it be intimately apposed to the bronchial 
stump and to fill any irregular cavity. 33 For these 
reasons we use the omentum preferentially to but- 
tress the repair of BPF. Muscle flaps are reserved 
for those cases in which omentum is unavailable or 
single-stage obliteration of the cavity is planned. 
The successful closure of major postoperative 
BPFs in 11 of 12 patients who had received 4000 to 
6800 cGy of preoperative radiation therapy was 
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particularly gratifying. As a general rule, if radiation 
therapy is over 4000 to 4500 cGy and is given more 
than 1 year before the operation, healing may be 
seriously impaired because of depressed prolifera- 
tion of capillaries and fibroblasts. 34In this situation, 
the special angiogenetic properties of the omentum 
are vital to successful repair of BPF. Omental pedicles 
were used in nine primary and one secondary epair of 
BPF after radiation therapy. Successful closure and 
healing were achieved in nine of these 10 cases, despite 
the longstanding duration of BPF in this subgroup 
(mean 4.3 years, range 1 month to 10 years). 
Reluctance to use the omental flap to control BPF 
because of fear of intraabdominal sepsis or hernia- 
tion is unjustified. No episode of intraabdominal 
sepsis or herniation of abdominal contents occurred 
in any of the 25 patients treated with omental 
pedicle flaps. 
Management of the residual pleural cavity can be 
accomplished in a variety of ways. In small, con- 
tracted cavities, little space remains after the omen- 
turn or muscle has been transposed, and nothing 
further need be done other than simple drainage. 
This was true for 16 patients in our series. Simple 
drainage may result in closure of the space over time 
if the cavity is kept clean. The length of time needed 
depends on the size of the cavity and the nutritional 
state of the patient. A large space can be closed at 
the time of BPF repair by muscle transposition or 
thoracoplasty orboth. This eliminates the need for a 
second-stage operation and the inconvenience of 
prolonged drainage of the cavity. When this ap- 
proach is chosen, we prefer muscle transposition 
over major thoracoplasty for cosmetic reasons. 
Residual pleural spaces may also be managed in a 
delayed fashion by muscle transposition or the 
Clagett procedure. 2aThe cavity taust be kept clean 
and drained during the interval. If a Clagett proce- 
dure is chosen the cavity taust be essentially sterile 
and the fistula successfully closed. Compromise on 
either of these conditions will doom the Clagett 
procedure to failure. We prefer the Clagett proce- 
dure as the least disfiguring, least morbid method of 
managing aclean residual pleural space. The overall 
success rate for the Clagett procedure in our series 
was 80% (8/10). This compares favorably with other 
reported success rates with the Clagett procedureY 
This gratifying result is likely due to careful patient 
selection and preparation based on principles of 
thorough pleural drainage and disinfection and suc- 
cessful prior closure of the BPF, preferably with 
omental buttressing. It is interesting that seven of 
the eight patients successfully treated by delayed 
Clagett procedure had prior BPF closure with 
omentum. This may be another demonstration of
the effectiveness of omentum in fighting infection. 
Conelusions 
Optimal results are obtained in patients with BPF 
by a two-stage approach. First, the pleura! cavity is 
thoroughly drained by closed or open thora¢ostomy 
and vigorously disinfected. Second, suture elosure of 
BPF is buttressed by a vascularized pedicle of 
omentum or muscle. A pleural flap alone is never 
use to buttress the elosure of BPF. The pleural 
eavity may be simultaneously obliterated, either by 
the bulk of the omentum or by some ¢ombination of 
myoplasty and thoracoplasty. A less morbid alterna- 
tive is a delayed Clagett procedure, after successful 
closure of BPF with omental transposition and 
thorough cleansing of the pleural space. It cannot be 
overemphasized that attempted ¢losure of BPF in 
the presence of suppurative infe¢tion is unlikely to 
succeed. Similarly, instillation of antibiotic solution 
and chest closure in the presence of infection or 
open BPF is doomed to failure. 
Management of postresectional BPF remains a 
major challenge. Successful outcome demands trict 
attention to technical details, optimization of the 
patient's general condition, and a clean pleural 
cavity. The method of closure should be individual- 
ized for each patient. Direct surgical repair of 
chronic BPF may be achieved in most patients after 
adequate pleural drainage by suture closure and 
aggressive transposition of vascularized pedicle 
flaps. Omentum is particularly effective in buttress- 
ing the closure of BPF. 
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Discuss ion 
Dr. Willard A. Fry (Evanston, IIL). I would like to ask 
you a few questions. First, what are the advantages of
omentum over mus¢le? Second, with the downstaging 
neoadjuvant programs coming on now with preoperative 
chemotherapy and radiation, particularly when both mod- 
els are used, from a preventative point of view, what are 
your procedures for reinforcing the bronchial closure, 
particularly with pneumonectomy? Third, in no instance 
here did you perform an operation that has attracted 
some attention, and that is the transsternal Perelman 
approach. I would like you to comment on that. 
Dr. Puskas. The advantages that we have seen to the 
omentum are several, in particular, its natural angiogen- 
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esis. Goldsmith identified in 1984 a lipid-soluble angio- 
genic factor isolated from omentum. Morgan in 1982 
proved that an autotransplanted bronchial stump wrapped 
in omentum was revascularized in 4 days, as documented 
by a celiac angiogram. DuBois and Lima in 1983 and 1984 
demonstrated that bronchial anastomotic complications in
canine allotransplantation a d autotransplantation, re-
speetively, were markedly reduced if the bronchial anas- 
tomosis was wrapped with omentum. Those studies were 
performed in Dr. Cooper's laboratory in Toronto. 
The second benefit or natural property of omentum 
that provides an advantage in buttressing a BPF closure is 
its bulk and amorphous shape. It can be mobilized from 
the abdomen, as I mentioned, to reach the apex of the 
chest in a vast majority of patients, it can be fashioned to 
fill any residual cavity, and it can be intimately opposed to 
a bronchial stump over its entire length. Finally, the 
omentum's natural design by God is to fight infection. It is 
the policeman of the abdomen, and it performs that role 
very well, better than any other organ in the body or any 
other tissue pedicle. Because the major problems with 
BPFs are ischemia nd infection, the natural angiogenic 
factor of omentum and its ability to fight infection make it 
a natural choice for a pedicle. 
The risk of BPF can be formidable, particularly in 
patients with downstaged IIIA disease undergoing pneu- 
monectomy, particularly in patients undergoing a right 
pneumonectomy after irradiation. This risk is further 
increased in elderly or diabetic patients receiving steroids. 
Under those circumstances the thoracic unit at the Mas- 
sachusetts General Hospital would probably buttress that 
right main-stem bronchial stump with omentum at the 
time of original pneumonectomy. An alternative would be 
a vascularized muscle flap, but the prejudice at the 
Massachusetts General Hospital has been in favor of 
omentum. 
The Perelman approach was used in two patients in our 
series of 42. The transthoracic/transpericardial approaeh 
was tried briefly in 1980 and 1981 and abandoned there- 
after. Dr. £erelman himself has abandoned the procedure 
for repair of BPF. The Perelman approach through the 
sternum and transpericardial dissection offers limited 
exposure, it is technically difficult to perform, and it is 
probably contraindicated in patients who have had irradi- 
ation. To be of any benefit at all, it requires that the stump 
be long. The purpose of the transpericardial pproach, of 
course, is to staple the bronchial stump and leave it in 
place. Leaving the bronchial stump in place predisposes to 
recurrent empyema nd to recurrent BPF. Alternatively, 
approaching the bronchial stump through the thorax 
allows the bronchial stump to be excised and removed and 
allows the option of closing or obliterating the pleural 
cavity at the time of the original repair, accomplishing a 
one-stage treatment for the BPF. We have found little or 
no indication for the Perelman procedure in the past 14 
years. 
Dr. Douglas J. Mathisen. I would like to clarify one 
point concerning the question that Dr. Fry asked about 
those patients whose disease has been downstaged with 
preoperative therapy. In general we have used pericar- 
dial fat pad flaps or intercostal muscles in a preventive 
sense and have used omentum sparingly, but on occa- 
sion, in that group of patients. We have used the 
omentum almost religiously whenever the dose has 
been in excess of 4000 rads and the duration between 
the interval when the radiation was given and when we 
see them is greater than a year. In that case we use the 
omentum exclusively. 
Dr. Fry. In conclusion, is the take-home message that 
you would reinforce the stump with perieardial fat after a 
right pneumonectomy in a patient who had had chemo- 
therapeutic downstaging? 
Dr. Mathisen. I would probably use intercostal musele. 
Many of us have also used the fat pad and would routinely 
do that in those patients who have had preoperative 
radiotherapy. 
